Another Lift & Co. (TSXV:LIFT,OTCQB:LFCOF) cannabis expo kicked off on Thursday (June 6), with the business-focused first day bringing investors insights from experts.

During the day, a collection of panelists involved in the marijuana business took to the stage to discuss the current issues and changes in the market.


Some of these projections and comments came from Vivien Azer, managing director for consumer research in the beverages, cannabis and tobacco markets for Cowen (NASDAQ:COWN). She believes that edibles and infused products won’t become available in Canada before the end of the year.

“I would be very, very surprised if there’s ingestible cannabis in Canada for sale at any point in 2019,” Azer said.

Peter Aceto, CEO of CannTrust Holdings (NYSE:CTST,TSX:TRST), agreed with his fellow panelist on the edibles timeline prediction.

During a separate panel on what Canadian companies can do to capitalize on the legalization path the US has gone through, Azer suggested that there is a roadmap ahead for US President Donald Trump to legalize marijuana in some form.

“We think that the administration could very well (do it) … it really just comes down to timing,” the analyst said.

Azer explained that Trump might feel compelled to increase his polling numbers closer to the 2020 election and work alongside Senate Majority Leader Mitch McConell to pass some form of legalization program or the much anticipated STATES Act.

The STATES Act is a proposed bill that would create protections at the federal level for operations made legal by policies at the state level.

During a fireside chat, Mark Zekulin, co-CEO of Canopy Growth (NYSE:CGC,TSX:WEED), explained how important it is for the firm to share its IP and brands with Acreage Holdings (CSE:ACRG.U,OTCQX:ACRGF) as part of a proposed acquisition deal.

An audience member asked Zekulin if the company will acquire more brands in the US; while the executive said the focus is to grow Canopy’s existing brands, he admitted the company won’t be blind to thriving products in markets such as California.

Europe panel highlights market opportunities

Investors in attendance also heard about the possibility of companies entering the European market.

Deepak Anand, CEO of Materia Ventures, said many companies still fail to understand how significant and complicated obtaining an EU-GMP certification status is for any expansion plans in Europe.

Guillermo Delmonte, a former Organigram Holdings (NASDAQ:OGI,TSXV:OGI) executive, said that securing this status is a laborious, complex task that will take any company a long time.

Delmonte, who is now chief operating officer and president of RAMM Pharma, said he is surprised whenever a company lists an expectation of securing an EU-GMP certification in six months or less.

When asked about the benefits of participating in the European market, Anand said from a capital markets point of view investors are looking for international strategies from companies.

Fellow panelist Darren Karasiuk, chief commercial officer for Aurora Cannabis (NYSE:ACB,TSX:ACB), said a strategy in Europe also offers stability by showing a company’s expansion capabilities.

Anand said that he expects Europe to become the largest cannabis market in the world.

At the end of the session, the event’s host, Deborah Rosati, who is CEO of Women Get on Board, asked the panelists what they wish could change in the current cannabis market.

Amanda de Freitas, board member for the Redfund Capital (CSE:LOAN,OTC Pink:PNNRF) and a marijuana compliance expert in Canada, answered by asking for more attention from the capital markets for late-stage licensed producers needing support for a last push.

“Our domestic markets, we have a little bit of a shift from our domestic capital markets into the European markets and global markets,” she said.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Chemesis International Inc. (the “Company”) (CSE: CSI) (OTC: CADMF) (FRA: CWAA) is pleased to announce that all matters submitted to the shareholders of the Company at the Annual General and Special Meeting of the Company’s shareholders held on December 31, 2020 were approved.
In addition, the Company has granted, pursuant to its Equity Incentive Plan, options to purchase 1,500,000 shares of the Company exercisable for a period of 5 years at USD$0.70 per share to the directors, officers and consultants of the Company. The Company has also granted, pursuant to its Equity Incentive Plan, restricted share rights to acquire 1,500,000 shares of the Company to the directors, officers and consultants of the Company. One-half of such restricted share rights shall vest in three months from the grant date and the remaining one-half shall vest in six months from the grant date.
On Behalf of The Board of Directors
Josh Rosenberg
President
Investor Relations:
ir@chemesis.com
1 (604) 398-3378
The CSE has not reviewed, approved or disapproved the content of this press release

Source

Keep reading... Show less

Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (“Nextleaf”, “OILS”, or the “Company”), the world’s most innovative cannabis extractor, announced today that the Canadian Intellectual Property Office has granted the Company a patent for the acetylation of cannabinoids. More specifically, the patent covers a process for acetylating cannabidiol (“CBD”), and subsequent refinement of CBD-O-Acetate using a proprietary extraction and distillation technique.

Keep reading... Show less

Codebase Ventures Inc. (“Codebase” or the “Company”) (CSE:CODE)(FSE:C5B)(OTCQB:BKLLF) The Company announces that it has recently negotiated an extension to its option to purchase another 21% of Arcology for another year by an investment of $1,000,000. If the company exercises that option, it would then own 51

The Company is clarifying that in its press release of January 15th regarding the signing of a definitive agreement to acquire bit mining infrastructure, that the first phase will deliver 9,450 terahash per second, not 9,450 petahash as stated.

Keep reading... Show less

Appointment of Philip Young as CEO and director adds a seasoned executive with a track record of new device and therapeutics development, FDA/regulatory approvals, capital markets, M&A and operational success

 Lobe Sciences Ltd (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) is pleased to announce the appointment of Mr. Philip J. Young as Chief Executive Officer, Corporate Secretary and a director of the Company, effective January 15, 2021. Mr. Young replaces Thomas Baird, who resigned as CEO as of the same date.

Keep reading... Show less

2020 Program Focused on Building Local Communities

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco Labs” or “the Company”), one of the largest vertically integrated, multistate cannabis operators in the United States, announced today its employees volunteered over 5,000 service hours during a seven-month period in 2020 as part of Cresco’s “Make a Difference” initiative.

Keep reading... Show less